Vaccine success: study reports fall in HPV infections in women in England
A recent study has demonstrated a significant decrease in cases of human papilloma virus infection in England since the introduction of a bivalent vaccine in 2008.
Browsing: Vaccines
Scientists set their sights on a new syphilis vaccine
Through a process of elimination, researchers have identified membrane surface proteins on T. pallaidum, which can be targeted by immune antibodies.
ASM Microbe: GeoVax present single-dose vaccines for Ebola, Lassa and Zika
At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
Creating equal access to vaccines – an interview with Gavi CEO, Seth Berkley
In our latest interview we ask Seth Berkley, who has been CEO of Gavi since 2011, about new vaccines, the importance of collaboration and the challenges facing access to vaccinations.
Screening and vaccination of migrants in Europe – an interview with Sally Hargreaves
In this interview Sally, a Senior Research Fellow at Imperial College London’s Faculty of Medicine (London, UK), speaks about her work on issues relating to the vaccination and screening of migrants, in addition to discussing some of the wider issues facing migrant’s access to healthcare in Europe.
Rabies: An ancient relic overdue for elimination thrives amongst the neglected tropical diseases
Rabies elimination is achievable and cost-effective, but decades of research have failed to translate into multi-national efforts in the worst-affected areas. So why is the ancient rabies virus still terrorizing the lives of so many people across the globe?
The evidence around vaccines – fact vs. myth
In light of World Immunization Week (24–30 April) we’ve taken a closer look at some of the myths surrounding vaccination, and the scientific evidence that contradicts these, find out more in our latest video.
Novel strategy offers yellow fever vaccine for almost 1 billion individuals in Africa by 2026
A novel initiative is working to ensure that approximately 1 billion individuals are vaccinated against yellow fever across 27 African countries by 2026.
Advances in vaccine manufacturing – a step toward recombinant production
Take a look at how advancements in genetic engineering has led to advances in vaccine manufacturing, with a divergence from live cell cultures to recombinant production in host cells.
Proof-of-concept study takes steps towards vaccine pills
A proof-of-concept study has demonstrated promise for a new vaccine production platform, which was used to build a prototype synthetic flu vaccine.
